Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Levofloxacin/linezolid/meropenem/piperacillin/tazobactam

Emergence and persistence of linezolid-resistant Enterococcus faecium infection: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Sanchez-Diaz AM, et al. Emergence and long-lasting persistence of linezolid-resistant enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid. Microbial Drug Resistance - Mechanisms, Epidemiology and Disease 20: 17-21, No. 1, Feb 2014. Available from: URL: http://doi.org/10.1089/mdr.2013.0034 - SpainCrossRef Sanchez-Diaz AM, et al. Emergence and long-lasting persistence of linezolid-resistant enterococcus faecium-ST117 in an oncohematologic patient after a nine-day course of linezolid. Microbial Drug Resistance - Mechanisms, Epidemiology and Disease 20: 17-21, No. 1, Feb 2014. Available from: URL: http://​doi.​org/​10.​1089/​mdr.​2013.​0034 - SpainCrossRef
Metadaten
Titel
Levofloxacin/linezolid/meropenem/piperacillin/tazobactam
Emergence and persistence of linezolid-resistant Enterococcus faecium infection: case report
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9979-0

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Ampicillin

Case report

Zolmitriptan

Case report

Rituximab

Case report

Escitalopram